Dry Eye Disease in Patients With Schizophrenia: A Case-Control Study

被引:4
|
作者
Chen, Qiankun [1 ]
Wei, Zhengjiang [2 ]
Wang, Leying [1 ]
Xu, Xizhan [1 ]
Wei, Zhenyu [1 ]
Zheng, Panpan [3 ]
Cao, Kai [1 ]
Zhang, Zijun [1 ]
Chen, Kexin [1 ]
Liang, Qingfeng [1 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol,Key Lab Ophthalmol & Visu, Beijing, Peoples R China
[2] Beijing Miyun Mental Hlth Prevent & Treatment Hos, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Beijing, Peoples R China
关键词
dry eye disease; schizophrenia; cytokine; inflammation; tear; MEIBOMIAN GLAND DYSFUNCTION; OCULAR SURFACE; CLINICAL SEVERITY; INFLAMMATORY CYTOKINES; DEPRESSION; MATRIX-METALLOPROTEINASE-9; ASSOCIATION; DISORDERS; SYMPTOMS; INTERLEUKIN-1;
D O I
10.3389/fmed.2022.831337
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveTo evaluate the clinical features and inflammatory cytokines of dry eye disease (DED) in patients with schizophrenia. MethodsThis is a case-control study. The modified self-rating depression scale (M-SDS) and the ocular surface disease index (OSDI) were used to evaluate the symptoms of depression and DED, respectively. Lipid layer thickness (LLT), partial blink rate (PBR), meibomian gland loss (MGL), tear break-up time (TBUT), corneal fluorescein staining, Schirmer I-test, and eyelid margin abnormalities were also measured. A multiplex ELISA Quantibody array was used to detect the inflammatory cytokines in the tears of all participants. ResultsForty schizophrenic patients and 20 control subjects were included. The mean age was 45.0 +/- 9.5 years (range, 22-63 years) in schizophrenic patients and 45.4 +/- 16.2 years (range, 23-76 years) in controls (P = 0.914). The ratio of male to female was 1.1 in schizophrenic patients and 1.0 in controls (P = 0.914). Ten women (52.6%) with schizophrenia and 2 (20%) in the control group (P = 0.096) were menopausal or post-menopausal. The OSDI [0.0 (0.0-4.2) vs. 7.3 (2.1-14.6)] and TBUT [4.5 (3.0-6.0) vs. 10.0 (3.5-11.0)] were significantly lower in patients with schizophrenia than in controls (P = 0.003 and P = 0.009, respectively). The rate of MGL [36.5 (17.5-47.5) vs. 8.5 (0.0-17.5)] increased in schizophrenic patients (P < 0.001). Among pro-inflammatory cytokines, the levels of interleukin (IL)-1 alpha, IL-6, IL-11, IL-12A, IL-15, IL-17A, and granulocyte colony-stimulating factor (G-CSF) in tears were elevated in the schizophrenia group (all P < 0.01). Most of the chemokines examined were at increased levels in the tears of schizophrenics (all P < 0.05). The levels of matrix metalloproteinases-9 (MMP-9) and intercellular adhesion molecule-1 (ICAM-1) were also higher in the schizophrenic patients (all P < 0.001). The concentrations of IL-1Ra, tissue-inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in the schizophrenia group were decreased (all P < 0.001). In schizophrenic patients, the level of CCL2 in tears was positively correlated with OSDI (R = 0.34, P = 0.03). The increasing TIMP-1 and decreasing IL-5 were correlated with increasing LLT (R = 0.33, P = 0.035; R = -0.35, P = 0.027, respectively). The level of ICAM-1 was then positively correlated with partial blink rate (PBR) (R = 0.33, P = 0.035). There was a negative correlation between IL-8 and the Schirmer I-test (R = -0.41, P = 0.009). ConclusionsPatients with schizophrenia were more likely to experience asymptomatic DED, with mild symptoms and obvious signs. The inflammatory cytokines in the tears of schizophrenic patients differed greatly from that of non-schizophrenic patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Somatotype and schizophrenia. A case-control study
    Pailhez, G.
    Rodriguez, A.
    Ariza, J.
    Palomo, A. L.
    Bulbena, A.
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2009, 37 (05): : 258 - 266
  • [32] Microvascular dysfunction in schizophrenia: A case-control study
    Vetter M.W.
    Martin B.-J.
    Fung M.
    Pajevic M.
    Anderson T.J.
    Raedler T.J.
    npj Schizophrenia, 1 (1):
  • [33] School achievements and schizophrenia:: A case-control study
    Hultman, CM
    Helling, I
    Wieselgren, IM
    Öhman, A
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 42 - 43
  • [34] Lifestyle and Symptom Risk Factors for Dry Eye Disease in Asian Gout Population: A Population-Based Case-Control Study
    Lee, Chia-Yi
    Lian, Ie-Bin
    Jhan, Yan-Ni
    Yang, Shun-Fa
    Chang, Chao-Kai
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
  • [35] Air Pollution and Tear Lactoferrin among Dry Eye Disease Modifications by Stress and Allergy: A Case-Control Study of Taxi Drivers
    Hao, Wei
    Kong, Fanxue
    Song, Wei
    Zhang, Lei
    Xu, Xueying
    Ren, Zhongjuan
    Li, Jing
    Yu, Fei
    ATMOSPHERE, 2022, 13 (12)
  • [36] A questionnaire-based survey of dry eye disease among leather tannery workers in Kanpur, India: a case-control study
    Gupta, Ramesh Chandra
    Ranjan, Ratnesh
    Kushwaha, Raj Nath
    Khan, Perwez
    Mohan, Shalini
    CUTANEOUS AND OCULAR TOXICOLOGY, 2014, 33 (04) : 265 - 269
  • [37] Predisposing factors for poor outcomes after intense pulsed light treatment for dry eye disease: A retrospective case-control study
    Lee, Chia-Yi
    Yang, Shun-Fa
    Chen, Hung-Chi
    Chang, Chao-Kai
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (15): : 2919 - 2925
  • [38] Cardiovascular Disease Risk in Schizophrenia Patients: A Case Control Study
    Joshi, Kedar B.
    Nillawar, Anup
    Thorat, A. P.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (12) : 2694 - 2696
  • [39] Characterising phospholipids and free fatty acids in patients with schizophrenia: A case-control study
    Wang, Dongfang
    Sun, Xiaoyu
    Maziade, Michel
    Mao, Wei
    Zhang, Chuanbo
    Wang, Jingyu
    Cao, Bing
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2021, 22 (03): : 161 - 174
  • [40] Peripheral non-enzymatic antioxidants in patients with schizophrenia: a case-control study
    Lu, Zhe
    Wen, Tianyang
    Wang, Yingtan
    Kan, Weijing
    Xun, Guanglei
    BMC PSYCHIATRY, 2020, 20 (01) : 241